Athelas has developed an in-home blood diagnostic device that is designed to monitor the immune system using just a drop of blood. This portable optical unit not only images the sample but also analyzes blood cells and generates diagnostic reports. This allows patients to monitor their immunity levels from home and aids doctors in early identification of leukemia, infections, and inflammatory diseases.

Investors Include:

Sequoia Capital, Initialized Capital Management, Human Capital, Cardinal Ventures, Greenoaks Capital Partners, USC Marshall School of Business, Fifty Years, Charles Reim, Shasta Ventures, Patrick Yang, Qasar Younis, Liquid 2 Ventures, General Catalyst, James Hong, LYVC, CSC UpShot Ventures, Georges Harik, Richard Socher, Joshua Buckley, Y Combinator, Dorm Room Fund, Elad Gil, Browder Capital, Tribe Capital, AIX Ventures.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund